Telix Investor Presentation April 2026
Filed with ASX · · 20 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
In the deck
Earlier from Telix Pharmaceuticals
- Telix Refinances Convertible Bonds
- Telix and Regeneron Announce Strategic Radiopharma Collaboration
- Regeneron and Telix Announce Strategic Radiopharma Collaboration
- Telix and Regeneron Announce Radiopharma Collaboration
- FDA Accepts NDA for TLX101-Px (Pixclara)
Later from Telix Pharmaceuticals
- Telix Successfully Prices Upsized US$600M Convertible Bonds
- Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
- Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
- ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
- Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals